Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Raw

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Age and Ageing|October 27, 2004
Are the days of bedrails coming to an end?Jason Raw, Simon Stacey
Age and Ageing|March 16, 2007
Hoof beatsJason Raw, Michael A Horan
BMJ (Clinical Research Ed.)|April 13, 2012
Identify hearing impairment and take actionNarveshwar Sinha, Jason Raw, Shabana Zafar
HCA Healthcare Journal of Medicine|November 12, 2025
Upper Respiratory Tract Infection Leading to a New Diagnosis of Sweet Syndrome and Monoclonal Gammopathy of Unknown SignificanceNidhi Rawat, Meron Gebrehiwot, Jason Raw, et al.
BJR Case Reports|March 31, 2023
Unusual case of a gigantic bladder mimicking a large pelvic cystic massMohammad Khadeem Rumjaun, Sana Amjed, Muhammad Anas Ghazi, et al.
Journal of Parkinson'S Disease|October 26, 2020
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES TrialGiovanni Abbruzzese, Jaime Kulisevsky, Bruno Bergmans, et al.
Journal of Parkinson'S Disease|July 19, 2021
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES TrialGiovanni Abbruzzese, Jaime Kulisevsky, Bruno Bergmans, et al.
Therapeutic Advances in Neurological Disorders|July 20, 2019
Parkinson's-adapted cognitive stimulation therapy: a pilot randomized controlled clinical trialIracema Leroi, Sabina Vatter, Lesley-Anne Carter, et al.
Journal of Neurology|June 5, 2019
Parkinson's-adapted cognitive stimulation therapy: feasibility and acceptability in Lewy body spectrum disordersSheree A McCormick, Sabina Vatter, Lesley-Anne Carter, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2022
Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized AnalysisYue Xing, Abdul Halim Sapuan, Antonio Martín-Bastida, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Age and Ageing|October 27, 2004
Are the days of bedrails coming to an end?Jason Raw, Simon Stacey
Age and Ageing|March 16, 2007
Hoof beatsJason Raw, Michael A Horan
BMJ (Clinical Research Ed.)|April 13, 2012
Identify hearing impairment and take actionNarveshwar Sinha, Jason Raw, Shabana Zafar
HCA Healthcare Journal of Medicine|November 12, 2025
Upper Respiratory Tract Infection Leading to a New Diagnosis of Sweet Syndrome and Monoclonal Gammopathy of Unknown SignificanceNidhi Rawat, Meron Gebrehiwot, Jason Raw, et al.
BJR Case Reports|March 31, 2023
Unusual case of a gigantic bladder mimicking a large pelvic cystic massMohammad Khadeem Rumjaun, Sana Amjed, Muhammad Anas Ghazi, et al.
Journal of Parkinson'S Disease|October 26, 2020
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES TrialGiovanni Abbruzzese, Jaime Kulisevsky, Bruno Bergmans, et al.
Journal of Parkinson'S Disease|July 19, 2021
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES TrialGiovanni Abbruzzese, Jaime Kulisevsky, Bruno Bergmans, et al.
Therapeutic Advances in Neurological Disorders|July 20, 2019
Parkinson's-adapted cognitive stimulation therapy: a pilot randomized controlled clinical trialIracema Leroi, Sabina Vatter, Lesley-Anne Carter, et al.
Journal of Neurology|June 5, 2019
Parkinson's-adapted cognitive stimulation therapy: feasibility and acceptability in Lewy body spectrum disordersSheree A McCormick, Sabina Vatter, Lesley-Anne Carter, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2022
Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized AnalysisYue Xing, Abdul Halim Sapuan, Antonio Martín-Bastida, et al.
Pageof 2